ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
ProPhase Labs's operating income for the twelve months ending Jun 30, 2026 was -$15.56M. For fiscal 2025 it was -$18.05M. The highest annual figure on record is $23.60M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.05M | – |
| FY2024 | Dec 31, 2024 | -$38.63M | – |
| FY2023 | Dec 31, 2023 | -$21.22M | -189.9% |
| FY2022 | Dec 31, 2022 | $23.60M | +140.7% |
| FY2021 | Dec 31, 2021 | $9.80M | – |
| FY2020 | Dec 31, 2020 | -$2.08M | – |
| FY2019 | Dec 31, 2019 | -$3.24M | – |
| FY2018 | Dec 31, 2018 | -$1.63M | – |
| FY2017 | Dec 31, 2017 | -$3.99M | – |
| FY2016 | Dec 31, 2016 | -$2.66M | – |
| FY2015 | Dec 31, 2015 | -$3.58M | – |
| FY2014 | Dec 31, 2014 | -$7.83M | -1981.7% |
| FY2013 | Dec 31, 2013 | $416.00K | – |
| FY2012 | Dec 31, 2012 | -$1.10M | – |
| FY2011 | Dec 31, 2011 | -$2.74M | – |
| FY2010 | Dec 31, 2010 | -$3.59M | – |
| FY2009 | Dec 31, 2009 | -$3.94M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.43M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.73M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.76M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.89M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.66M | – |
| Q4 FY2024 | Dec 31, 2024 | -$17.29M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.48M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.23M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.63M | -972.1% |
| Q4 FY2023 | Dec 31, 2023 | -$10.96M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.48M | -431.7% |
| Q2 FY2023 | Jun 30, 2023 | -$4.66M | -144.0% |
| Q1 FY2023 | Mar 31, 2023 | $875.00K | -94.6% |
| Q4 FY2022 | Dec 31, 2022 | -$5.09M | -137.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.95M | – |
| Q2 FY2022 | Jun 30, 2022 | $10.59M | – |
| Q1 FY2022 | Mar 31, 2022 | $16.15M | +1222.4% |
| Q4 FY2021 | Dec 31, 2021 | $13.68M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.65M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.45M | -2557.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.22M | – |
| Q4 FY2020 | Dec 31, 2020 | -$761.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$567.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $59.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$812.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$466.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$461.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.27M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.04M | – |
| Q4 FY2018 | Dec 31, 2018 | -$406.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$912.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$264.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$53.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$332.00K | -143.6% |
| Q3 FY2017 | Sep 30, 2017 | -$902.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$886.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$745.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $761.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$786.00K | – |
See a number that looks wrong?